Claudio Dagostin

Synthesis and Evaluation of Two ¹⁸F-Labeled 6-Iodo-2-(4‘-<i>N</i>,<i>N</i>-dimethylamino)phenylimidazo[1,2-<i>a</i>]pyridine Derivatives as Prospective Radioligands for β-Amyloid in Alzheimer's Disease

Lisheng Cai, Frederick T. Chin, Victor W. Pike et al. · Journal of Medicinal Chemistry · 2004 · 87 citations

Medicine, Chemistry, Nuclear Medicine +14

A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death

Duncan E. Scott, Nicola J. Francis-Newton, M. Marsh et al. · Cell chemical biology · 2021 · 56 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +17

Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors

Young Shin Cho, Hayley C. Angove, Christopher T. Brain et al. · ACS Medicinal Chemistry Letters · 2012 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and Structure−Affinity Relationships of New 4-(6-Iodo-<i>H</i>-imidazo[1,2-<i>a</i>]pyridin-2-yl)-<i>N</i>-dimethylbenzeneamine Derivatives as Ligands for Human β-Amyloid Plaques

Lisheng Cai, Jessica Cuevas, J. Sebastian Temme et al. · Journal of Medicinal Chemistry · 2007 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Structure Based Drug Design: Development of Potent and Selective Factor IXa (FIXa) Inhibitors

Shouming Wang, Richard Beck, Andrew Burd et al. · Journal of Medicinal Chemistry · 2010 · 29 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17